Certainly, there have been a number of efforts to improve treatment options for cancer, most notably by exploring various inhibitors (most recently HSP90 C-terminal inhibitors) in order to understand the molecular and cellular determinants harboring any clinical relevance [4,5,6]. The gene discussed is HSP90AB1; the disease is cancer.